Novavax starts Phase IIb trial of Covid-19 vaccine in South Africa
US-based biotechnology company Novavax has launched a Phase IIb clinical trial of its Covid-19 vaccine candidate, NVX-CoV2373, in South Africa.
Source: Novavax starts Phase IIb trial of Covid-19 vaccine in South Africa